Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

NCT02670707 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis

Interventions

DRUG: Cytarabine
DRUG: Vinblastine/prednisone

Sponsor

Baylor College of Medicine